<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">EMBO J</journal-id>
<journal-id journal-id-type="iso-abbrev">EMBO J</journal-id>
<journal-id journal-id-type="doi">10.1002/(ISSN)1460-2075</journal-id>
<journal-id journal-id-type="publisher-id">EMBJ</journal-id>
<journal-id journal-id-type="hwp">embojnl</journal-id>
<journal-title-group>
<journal-title>The EMBO Journal</journal-title>
</journal-title-group>
<issn pub-type="ppub">0261-4189</issn>
<issn pub-type="epub">1460-2075</issn>
<publisher>
<publisher-name>John Wiley and Sons Inc.</publisher-name>
<publisher-loc>Hoboken</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">28069708</article-id>
<article-id pub-id-type="pmc">5437815</article-id>
<article-id pub-id-type="doi">10.15252/embj.201694314</article-id>
<article-id pub-id-type="publisher-id">EMBJ201694314</article-id>
<article-categories>
<subj-group subj-group-type="overline">
<subject>Article</subject>
</subj-group>
<subj-group subj-group-type="heading">
<subject>Articles</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Ubiquitylation‐dependent oligomerization regulates activity of Nedd4 ligases</article-title>
<alt-title alt-title-type="left-running-head">Ilan Attali <italic>et al</italic></alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" id="embj201694314-cr-0001">
<name>
<surname>Attali</surname>
<given-names>Ilan</given-names>
</name>
<xref ref-type="aff" rid="embj201694314-aff-0001">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="embj201694314-cr-0002">
<name>
<surname>Tobelaim</surname>
<given-names>William Sam</given-names>
</name>
<xref ref-type="aff" rid="embj201694314-aff-0002">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="embj201694314-cr-0003">
<name>
<surname>Persaud</surname>
<given-names>Avinash</given-names>
</name>
<xref ref-type="aff" rid="embj201694314-aff-0003">
<sup>3</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="embj201694314-cr-0004">
<name>
<surname>Motamedchaboki</surname>
<given-names>Khatereh</given-names>
</name>
<xref ref-type="aff" rid="embj201694314-aff-0004">
<sup>4</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="embj201694314-cr-0005">
<name>
<surname>Simpson‐Lavy</surname>
<given-names>Kobi J</given-names>
</name>
<xref ref-type="aff" rid="embj201694314-aff-0005">
<sup>5</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="embj201694314-cr-0006">
<name>
<surname>Mashahreh</surname>
<given-names>Bayan</given-names>
</name>
<xref ref-type="aff" rid="embj201694314-aff-0006">
<sup>6</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="embj201694314-cr-0007">
<name>
<surname>Levin‐Kravets</surname>
<given-names>Olga</given-names>
</name>
<xref ref-type="aff" rid="embj201694314-aff-0001">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="embj201694314-cr-0008">
<name>
<surname>Keren‐Kaplan</surname>
<given-names>Tal</given-names>
</name>
<xref ref-type="aff" rid="embj201694314-aff-0001">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="embj201694314-cr-0009">
<name>
<surname>Pilzer</surname>
<given-names>Inbar</given-names>
</name>
<xref ref-type="aff" rid="embj201694314-aff-0001">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="embj201694314-cr-0010">
<name>
<surname>Kupiec</surname>
<given-names>Martin</given-names>
</name>
<xref ref-type="aff" rid="embj201694314-aff-0005">
<sup>5</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="embj201694314-cr-0011">
<name>
<surname>Wiener</surname>
<given-names>Reuven</given-names>
</name>
<xref ref-type="aff" rid="embj201694314-aff-0006">
<sup>6</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="embj201694314-cr-0012">
<name>
<surname>Wolf</surname>
<given-names>Dieter A</given-names>
</name>
<xref ref-type="aff" rid="embj201694314-aff-0004">
<sup>4</sup>
</xref>
<xref ref-type="aff" rid="embj201694314-aff-0007">
<sup>7</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="embj201694314-cr-0013">
<name>
<surname>Rotin</surname>
<given-names>Daniela</given-names>
</name>
<xref ref-type="aff" rid="embj201694314-aff-0003">
<sup>3</sup>
</xref>
</contrib>
<contrib contrib-type="author" corresp="yes" id="embj201694314-cr-0014">
<name>
<surname>Prag</surname>
<given-names>Gali</given-names>
</name>
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-4703-7161</contrib-id>
<address>
<email>prag@post.tau.ac.il</email>
</address>
<xref ref-type="aff" rid="embj201694314-aff-0001">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="embj201694314-aff-0008">
<sup>8</sup>
</xref>
</contrib>
</contrib-group>
<aff id="embj201694314-aff-0001">
<label>
<sup>1</sup>
</label>
<named-content content-type="organisation-division">Department of Biochemistry and Molecular Biology</named-content>
<named-content content-type="organisation-division">the George S. Wise Faculty of Life Sciences</named-content>
<institution>Tel Aviv University</institution>
<named-content content-type="city">Tel Aviv</named-content>
<country country="IL">Israel</country>
</aff>
<aff id="embj201694314-aff-0002">
<label>
<sup>2</sup>
</label>
<named-content content-type="organisation-division">Department of Physiology &amp; Pharmacology</named-content>
<institution>Sackler Tel Aviv University</institution>
<named-content content-type="city">Tel Aviv</named-content>
<country country="IL">Israel</country>
</aff>
<aff id="embj201694314-aff-0003">
<label>
<sup>3</sup>
</label>
<named-content content-type="organisation-division">Cell Biology Program</named-content>
<named-content content-type="organisation-division">The Hospital for Sick Children and Biochemistry Department</named-content>
<institution>University of Toronto</institution>
<named-content content-type="city">Toronto</named-content>
<named-content content-type="country-part">ON</named-content>
<country country="CA">Canada</country>
</aff>
<aff id="embj201694314-aff-0004">
<label>
<sup>4</sup>
</label>
<named-content content-type="organisation-division">Tumor Initiation &amp; Maintenance Program and NCI Cancer Centre Proteomics Facility</named-content>
<institution>Sanford Burnham Prebys Medical Discovery Institute</institution>
<named-content content-type="city">La Jolla</named-content>
<named-content content-type="country-part">CA</named-content>
<country country="US">USA</country>
</aff>
<aff id="embj201694314-aff-0005">
<label>
<sup>5</sup>
</label>
<named-content content-type="organisation-division">Department of Molecular Microbiology and Biotechnology</named-content>
<named-content content-type="organisation-division">the George S. Wise Faculty of Life Sciences</named-content>
<institution>Tel Aviv University</institution>
<named-content content-type="city">Tel Aviv</named-content>
<country country="IL">Israel</country>
</aff>
<aff id="embj201694314-aff-0006">
<label>
<sup>6</sup>
</label>
<named-content content-type="organisation-division">Department of Biochemistry and Molecular Biology</named-content>
<named-content content-type="organisation-division">Institute for Medical Research Israel‐Canada</named-content>
<institution>Hebrew University‐Hadassah Medical School</institution>
<named-content content-type="city">Jerusalem</named-content>
<country country="IL">Israel</country>
</aff>
<aff id="embj201694314-aff-0007">
<label>
<sup>7</sup>
</label>
<named-content content-type="organisation-division">School of Pharmaceutical Sciences</named-content>
<institution>Xiamen University</institution>
<named-content content-type="city">Xiamen</named-content>
<country country="CN">China</country>
</aff>
<aff id="embj201694314-aff-0008">
<label>
<sup>8</sup>
</label>
<named-content content-type="organisation-division">Sagol School of Neuroscience</named-content>
<institution>Tel Aviv University</institution>
<named-content content-type="city">Tel Aviv</named-content>
<country country="IL">Israel</country>
</aff>
<author-notes>
<corresp id="correspondenceTo"><label>*</label>Corresponding author. Tel: +972 3 640 9828; Fax: +972 3 640 6834; E‐mail: <email>prag@post.tau.ac.il</email></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>09</day>
<month>1</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="ppub">
<day>15</day>
<month>2</month>
<year>2017</year>
</pub-date>
<volume>36</volume>
<issue>4</issue>
<issue-id pub-id-type="doi">10.1002/embj.v36.4</issue-id>
<fpage>425</fpage>
<lpage>440</lpage>
<history>
<date date-type="received">
<day>13</day>
<month>3</month>
<year>2016</year>
</date>
<date date-type="rev-recd">
<day>25</day>
<month>11</month>
<year>2016</year>
</date>
<date date-type="accepted">
<day>06</day>
<month>12</month>
<year>2016</year>
</date>
</history>
<permissions>
<!--<copyright-statement content-type="issue-copyright"> &#x000a9; 2017 EMBO <copyright-statement>-->
<copyright-statement content-type="article-copyright">© 2017 The Authors</copyright-statement>
</permissions>
<self-uri content-type="pdf" xlink:href="file:EMBJ-36-425.pdf" xlink:type="simple"></self-uri>
<abstract id="embj201694314-abs-0001">
<title>Abstract</title>
<p>Ubiquitylation controls protein function and degradation. Therefore, ubiquitin ligases need to be tightly controlled. We discovered an evolutionarily conserved allosteric restraint mechanism for Nedd4 ligases and demonstrated its function with diverse substrates: the yeast soluble proteins Rpn10 and Rvs167, and the human receptor tyrosine kinase <styled-content style="fixed-case">FGFR</styled-content>1 and cardiac I<sub>KS</sub> potassium channel. We found that a potential trimerization interface is structurally blocked by the <styled-content style="fixed-case">HECT</styled-content> domain α1‐helix, which further undergoes ubiquitylation on a conserved lysine residue. Genetic, bioinformatics, biochemical and biophysical data show that attraction between this α1‐conjugated ubiquitin and the <styled-content style="fixed-case">HECT</styled-content> ubiquitin‐binding patch pulls the α1‐helix out of the interface, thereby promoting trimerization. Strikingly, trimerization renders the ligase inactive. Arginine substitution of the ubiquitylated lysine impairs this inactivation mechanism and results in unrestrained <styled-content style="fixed-case">FGFR</styled-content>1 ubiquitylation in cells. Similarly, electrophysiological data and <styled-content style="fixed-case">TIRF</styled-content> microscopy show that <styled-content style="fixed-case">NEDD</styled-content>4 unrestrained mutant constitutively downregulates the I<sub>KS</sub> channel, thus confirming the functional importance of E3‐ligase autoinhibition.</p>
</abstract>
<kwd-group kwd-group-type="author-generated">
<kwd id="embj201694314-kwd-0001">inactivation</kwd>
<kwd id="embj201694314-kwd-0002">Nedd4</kwd>
<kwd id="embj201694314-kwd-0003">oligomerization</kwd>
<kwd id="embj201694314-kwd-0004">Rsp5</kwd>
<kwd id="embj201694314-kwd-0005">ubiquitylation</kwd>
</kwd-group>
<kwd-group kwd-group-type="subject-categories">
<title>Subject Categories</title>
<kwd>Post-translational Modifications, Proteolysis &amp; Proteomics</kwd>
</kwd-group>
<funding-group>
<award-group>
<funding-source>Israel Science Foundation</funding-source>
<award-id>1695/08</award-id>
<award-id>464/11</award-id>
</award-group>
</funding-group>
<funding-group>
<award-group>
<funding-source>Seventh Framework Programme</funding-source>
<award-id>PIRG03‐GA‐ 2008‐231079</award-id>
</award-group>
</funding-group>
<funding-group>
<award-group>
<funding-source>Ministry of Health, Israel</funding-source>
<award-id>5108</award-id>
</award-group>
</funding-group>
<funding-group>
<award-group>
<funding-source>Marianna and Jorge Saia Fund for HIV and Parkinson Diseases</funding-source>
</award-group>
</funding-group>
<funding-group>
<award-group>
<funding-source>Constantiner Institute for Molecular Genetics</funding-source>
</award-group>
</funding-group>
<funding-group>
<award-group>
<funding-source>Anat Krauskopf Travel Fund</funding-source>
</award-group>
</funding-group>
<funding-group>
<award-group>
<funding-source>US National Institutes of Health</funding-source>
<award-id>GM105802‐01A1</award-id>
<award-id>CA030199‐32</award-id>
<award-id>GM085764‐03</award-id>
</award-group>
</funding-group>
<funding-group>
<award-group>
<funding-source>Canadian Institutes of Health Research</funding-source>
<award-id>MOP‐130422</award-id>
</award-group>
</funding-group>
<funding-group>
<award-group>
<funding-source>Canada Foundation for Innovation</funding-source>
</award-group>
</funding-group>
<funding-group>
<award-group>
<funding-source>Israel Cancer Research Fund</funding-source>
</award-group>
</funding-group>
<counts>
<fig-count count="12"></fig-count>
<table-count count="0"></table-count>
<page-count count="16"></page-count>
<word-count count="11858"></word-count>
</counts>
<custom-meta-group>
<custom-meta>
<meta-name>source-schema-version-number</meta-name>
<meta-value>2.0</meta-value>
</custom-meta>
<custom-meta>
<meta-name>component-id</meta-name>
<meta-value>embj201694314</meta-value>
</custom-meta>
<custom-meta>
<meta-name>cover-date</meta-name>
<meta-value>15 February 2017</meta-value>
</custom-meta>
<custom-meta>
<meta-name>details-of-publishers-convertor</meta-name>
<meta-value>Converter:WILEY_ML3GV2_TO_NLMPMC version:5.0.9 mode:remove_FC converted:22.05.2017</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
<notes>
<p content-type="self-citation">
<mixed-citation id="embj201694314-cit-1001" publication-type="journal">
<source/>The EMBO Journal (<year>2017</year>) <volume>36</volume>: <fpage>425</fpage>–<lpage>440</lpage>
<pub-id pub-id-type="pmid">28069708</pub-id></mixed-citation>
</p>
</notes>
<notes>
<p><related-article ext-link-type="doi" id="embj201694314-note-1001" related-article-type="companion" xlink:href="10.15252/embj.201696154"></related-article>See also: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.15252/embj.201696154">S Hill &amp; G Kleiger</ext-link> (February 2017)</p>
</notes>
</front>
</article>
</pmc-articleset>